SCI Ventures
Overview
SCI Ventures is a venture philanthropy fund dedicated to reversing paralysis by investing in scientific breakthroughs in spinal cord injury treatment. It invests in early-stage companies developing cure-oriented therapies for spinal cord injury, leveraging scientific advancements in neuron restoration, neuromodulation, and gene therapy. SCI Ventures focuses on seed and Series A financing rounds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Precision Neuroscience | Nov 2025 | Strategic | Lead |
| Cyllene Therapeutics | Feb 2025 | Series B | Co-investor |
| Axonis Therapeutics | Oct 2024 | Series A | Co-investor |
| Tatakai | Nov 2025 | Angel | Co-investor |
| Sania Therapeutics | May 2024 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SCI Ventures based?
SCI Ventures is headquartered in London, England, United Kingdom.
When was SCI Ventures founded?
SCI Ventures was founded in 2024.
How many portfolio companies does SCI Ventures have?
SCI Ventures has 5 portfolio companies in Caplight's dataset.
What are some companies in SCI Ventures's portfolio?
Portfolio companies visible on Caplight include Precision Neuroscience, Cyllene Therapeutics, Axonis Therapeutics, Tatakai, Sania Therapeutics.
What was SCI Ventures's most recent investment shown here?
SCI Ventures's most recent investment in this portfolio sample was in Precision Neuroscience in 2025.
What sectors does SCI Ventures focus on?
SCI Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Media, Entertainment & Gaming, Crypto & Web3, Frontier & Industrial Tech.
What company stages does SCI Ventures focus on?
SCI Ventures typically invests at the Early stage.
What is SCI Ventures's AUM?
SCI Ventures's assets under management are estimated between $0.0 and $50.0M.